Pharmacokinetics, Biodistribution and Therapeutic Efficacy of Doxorubicin Encapsulated in Stealth® Liposomes (Doxil®)

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Liposome Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.3109/08982109409037065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts

  1994cited by this paper
• Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes.

  1993cited by this paper
• Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes

  1993cited by this paper
• Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue.

  1993cited by this paper
• Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene.

  1993cited by this paper
• Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes

  1993cited by this paper
• Gelation of liposome interior A novel method for drug encapsulation

  1992cited by this paper
• Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice.

  1992cited by this paper
• Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.

  1992cited by this paper
• Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid

  1992cited by this paper
• Polymer-Grafted Liposomes: Physical Basis for the “Stealth” Property

  1992cited by this paper
• Sterically stabilized liposomes.

  1992cited by this paper
• Repulsive interactions and mechanical stability of polymer-grafted lipid membranes.

  1992cited by this paper
• Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes

  1992cited by this paper
• Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times.

  1991cited by this paper
• Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

  1991cited by this paper
• Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissues.

  1991cited by this paper
• Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times.

  1989cited by this paper
• Pharmacokinetics and pharmacodynamics of long‐term continuous‐infusion doxorubicin

  1989cited by this paper
• Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

  1988cited by this paper
• Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

  1988cited by this paper
• Continuous venous infusion of doxorubicin in advanced sarcomas.

  1987cited by this paper
• Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38.

  1987cited by this paper
• Large unilamellar liposomes with low uptake into the reticuloendothelial system

  1987cited by this paper
• Cancer chemotherapy and skin changes.

  1985cited by this paper
• Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.

  1984cited by this paper
• Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.

  1982cited by this paper
• Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin.

  1979cited by this paper
• Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity.

  1976cited by this paper

• Oral Doxorubicin Lipid Nanoparticles Enhance Triple‐Negative Breast Cancer Therapy via Immune Activation and Reduced Cardiotoxicity

  2025cites this paper
• Preclinical Studies on the Photothermal Therapy of NIR-II AIEgens: Across Tumor Types.

  2025cites this paper
• Antibody–drug conjugates in cancer therapy: current landscape, challenges, and future directions

  2025cites this paper
• Critical Quality Attributes of Lipid Nanoparticles and In Vivo Fate

  2025cites this paper
• Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery

  2025cites this paper
• Navigating the Clinical Landscape of Liposomal Therapeutics in Cancer Treatment

  2025cites this paper
• Bio-inspired, programmable biomacromolecules based nanostructures driven cancer therapy.

  2025cites this paper
• Biomimetic liposomes in drug delivery: from design mechanisms to applications

  2025cites this paper
• Multiple strategies approach: A novel crosslinked hydrogel forming chitosan-based microneedles chemowrap patch loaded with 5-fluorouracil liposomes for chronic wound cancer treatment.

  2024cites this paper
• Blood vessel wall shear stress determines regions of liposome accumulation in angiogenic vasculature

  2024cites this paper
• Ultrasound-triggered drug release and cytotoxicity of microbubbles with diverse drug attributes

  2024cites this paper
• Yolk-shell cationic liposomes overcome mucus and epithelial barriers for enhanced oral drug delivery

  2024cites this paper
• Liposomes in Cancer Therapy: How Did We Start and Where Are We Now

  2023cites this paper
• PNIPAM-stabilized cubosomes as fusogenic delivery nanovectors for anticancer applications.

  2023cites this paper
• Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy

  2023cites this paper
• Remote Loading: The Missing Piece for Achieving High Drug Payload and Rapid Release in Polymeric Microbubbles

  2023cites this paper
• The relationship between surface drug distribution of Dox-loaded microbubbles and drug release/cavitation behaviors with ultrasound

  2023cites this paper
• High-Throughput Method for the Simultaneous Determination of Doxorubicin Metabolites in Rat Urine after Treatment with Different Drug Nanoformulations

  2022cites this paper
• Delineating the tumour microenvironment response to a lipid nanoparticle formulation.

  2022cites this paper
• Placental Nanoparticle Uptake-On-a-Chip: The Impact of Trophoblast Syncytialization and Shear Stress.

  2022cites this paper
• Enhanced delivery to brain using sonosensitive liposome and microbubble with focused ultrasound.

  2022cites this paper
• Laurus nobilis L. Essential Oil-Loaded PLGA as a Nanoformulation Candidate for Cancer Treatment

  2022cites this paper
• A physiologically based pharmacokinetic model to predict pegylated liposomal doxorubicin disposition in rats and human

  2022influential citation
• Consideration for the scale‐up manufacture of nanotherapeutics—A critical step for technology transfer

  2021cites this paper
• Lignin-Stabilized Doxorubicin Microemulsions: Synthesis, Physical Characterization, and In Vitro Assessments

  2021cites this paper
• Extracellular Vesicles Mediate the Intercellular Exchange of Nanoparticles

  2021cites this paper
• Biodistribution of Polymeric, Polysaccharide and Metallic Nanoparticles

  2021cites this paper
• Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically‐based pharmacokinetic modeling

  2020cites this paper
• Theranostic Attributes of Acoustic Cluster Therapy and Its Use for Enhancing the Effectiveness of Liposomal Doxorubicin Treatment of Human Triple Negative Breast Cancer in Mice

  2020cites this paper
• Nanotechnology and drug delivery

  2020cites this paper
• Targeting CD4+ Cells with Anti-CD4 Conjugated Mertansine Loaded Nanogels.

  2020cites this paper
• A systematic review of the biodistribution of biomimetic high-density lipoproteins in mice.

  2020cites this paper
• Iron-crosslinked Rososome with robust stability and high drug loading for synergistic cancer therapy.

  2020cites this paper
• Amphiphilic Poly(2-isopropyl-2-oxazoline)-block-poly(lactide) Nanoparticles as Drug Delivery Vehicles

  2020cites this paper
• Targeting the tumor core: hypoxia-responsive nanoparticles for delivery of chemotherapy to pancreatic tumors.

  2020cites this paper
• Development of Liposomal Gemcitabine with High Drug Loading Capacity.

  2019cites this paper
• Preparation and Characterization of PEGylated C18 Fatty Acids/Anti-SNAP25 Antibody-Targeted Liposomes

  2019cites this paper
• Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic effects

  2019cites this paper
• Nanotechnology Toward Treating Cancer

  2019cites this paper
• Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy

  2019cites this paper
• Toxicological study of a new doxorubicin‐loaded pH‐sensitive liposome: A preclinical approach

  2018cites this paper
• Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment

  2018cites this paper
• A minimal physiologically based pharmacokinetic model that predicts anti‐PEG IgG‐mediated clearance of PEGylated drugs in human and mouse

  2018cites this paper
• Selective Targeting and Eradication of LGR5+ Cancer Stem Cells Using RSPO-Conjugated Doxorubicin Liposomes

  2018cites this paper
• Interaction between C18 fatty acids and DOPE PEG2000 in Langmuir monolayers: effect of degree of unsaturation

  2017cites this paper
• Interaction between C18 fatty acids and DOPE PEG2000 in Langmuir monolayers: effect of degree of unsaturation

  2017cites this paper
• Stimuli-responsive liposome and control release drug

  2017cites this paper
• Enhanced efficacy of combination heat shock targeted polymer therapeutics with high intensity focused ultrasound.

  2017cites this paper
• Tumor microenvironment determines response to a heat-activated thermosensitive liposome formulation of cisplatin in cervical carcinoma.

  2017cites this paper
• Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells

  2016cites this paper
• Analytical Utility of Liposomes: From Past to Present

  2016cites this paper
• New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy.

  2016cites this paper
• Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

  2016cites this paper
• Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer

  2016influential citation
• Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy.

  2016cites this paper
• Improving Anticancer Therapy with ELP-based Drug Delivery Systems

  2016cites this paper
• Narrow Absorption NIR Wavelength Organic Nanoparticles Enable Multiplexed Photoacoustic Imaging.

  2016cites this paper
• Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes.

  2015cites this paper
• Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug

  2015cites this paper
• The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes

  2015cites this paper
• Integration of imaging into clinical practice to assess the delivery and performance of macromolecular and nanotechnology-based oncology therapies.

  2015cites this paper
• Dynamics of Chemotherapeutic Drug Release from Liposomes Using Low-Frequency Ultrasound

  2015cites this paper
• Magnetic resonance guided high-intensity focused ultrasound for image-guided temperature-induced drug delivery.

  2014cites this paper
• Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina

  2014cites this paper
• Liposome mediated drug delivery for leukocyte adhesion deficieny I (LAD I): Targeting the mutated gene ITGB2 and expression of CD18 protein

  2014cites this paper
• Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.

  2014cites this paper
• Development of thermal sensitive liposomes for targeted delivery and controlled release of drug

  2014cites this paper
• Design, synthesis, and functionalization of nanomaterials for therapeutic drug delivery.

  2014cites this paper
• Temperature-responsive polymeric micelles for optimizing drug targeting to solid tumors.

  2014cites this paper
• Nanomedicines for Cancer Therapy: An Update of FDA Approved and Those under Various Stages of Development

  2014cites this paper
• Nanotechnology and tumor microcirculation.

  2014cites this paper
• A continuous flow method for estimation of drug release rates from emulsion formulations.

  2014cites this paper
• EPR: Evidence and fallacy.

  2014cites this paper
• Nanomedicines for Cancer Therapy : An Update of FDA Approved and Those under Various Stages of Development

  2014cites this paper
• Liposomes generated from proliposomes for treatment of glioma using Momordica charantia extracts

  2013cites this paper
• Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.

  2013cites this paper
• Magnetic Resonance Guided High-Intensity Focused Ultrasound Mediated Hyperthermia Improves the Intratumoral Distribution of Temperature-Sensitive Liposomal Doxorubicin

  2013cites this paper
• Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors

  2013cites this paper
• Carrier-Mediated and Targeted Cancer Drug Delivery

  2012cites this paper
• Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance

  2012cites this paper
• Polyethylene Glycol-Liposomal Doxorubicin

  2012cites this paper
• Poly(LA-co-TMCC)-graft-PEG Self-assembled Polymeric Nanoparticles for Targeted Drug Delivery

  2012cites this paper
• A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma.

  2011cites this paper
• Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.

  2011cites this paper
• Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study.

  2011cites this paper
• Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate.

  2011cites this paper
• Systèmes vésiculaires colloïdaux pour la vectorisation de la 1-β-D-arabinofuranosylcytosine

  2010cites this paper
• Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours

  2010cites this paper
• pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells.

  2009cites this paper
• Concept and clinical evaluation of carrier-mediated anticancer agents.

  2008cites this paper
• Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development.

  2008cites this paper
• Chapter 39 – Drug Solubilization with Organic Solvents, or Using Micellar Solutions or Other Colloidal Dispersed Systems

  2008cites this paper
• A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours

  2007cites this paper
• Role of anthracyclines in the era of targeted therapy

  2007cites this paper
• A Dose-Escalation Study of Pegylated Liposomal Doxorubicin and Oxaliplatin in Patients with Advanced Solid Tumors

  2007cites this paper
• 21 – Carrier-mediated and artificial-cell targeted cancer drug delivery

  2007cites this paper
• Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: Insights of the mechanism of action

  2007cites this paper
• Liposomal, Nanoparticle, and Conjugated Formulations of Anticancer Agents

  2005cites this paper
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

  2004cites this paper
• Advantages of liposomal delivery systems for anthracyclines.

  2004cites this paper